$CHMX
NEXT-ChemX Corporation.

2022 Q3 Form 10-Q Financial Statement

#000149315222022720 Filed on August 15, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $387.9K $438.3K $374.1K
YoY Change -12.05% -8.01% 2146.91%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.340K $1.290K $1.200K
YoY Change -99.24% -99.26%
% of Gross Profit
Operating Expenses $387.9K $438.3K $374.1K
YoY Change -12.05% 47.08% 2146.91%
Operating Profit -$387.9K -$438.3K -$374.1K
YoY Change -12.05% 47.08%
Interest Expense -$13.59K -$16.22K -$13.78K
YoY Change 60.45% 483.45%
% of Operating Profit
Other Income/Expense, Net -$13.59K -$16.22K -$13.78K
YoY Change -281.65% -53.88%
Pretax Income -$401.5K -$454.5K -$387.9K
YoY Change -7.39% -5.16% 2229.67%
Income Tax
% Of Pretax Income
Net Earnings -$401.5K -$454.5K -$387.9K
YoY Change -7.39% 36.42% 2229.67%
Net Earnings / Revenue
Basic Earnings Per Share -$0.01 -$0.02 -$0.01
Diluted Earnings Per Share -$14.34K -$16.28K -$14.16K
COMMON SHARES
Basic Shares Outstanding 28.02M shares 27.91M shares 27.39M shares
Diluted Shares Outstanding 28.00M shares 27.91M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $90.00 $52.55K $17.99K
YoY Change -92.11% -71.08% 8.11%
Cash & Equivalents $94.00 $52.55K $17.99K
Short-Term Investments
Other Short-Term Assets $2.900K $1.600K $1.600K
YoY Change -95.29% -97.4% 25.98%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $2.994K $54.15K $19.59K
YoY Change -95.23% -77.74% 9.38%
LONG-TERM ASSETS
Property, Plant & Equipment $19.29K $20.63K $20.34K
YoY Change -15.17% 38.42%
Goodwill
YoY Change
Intangibles $3.150M $3.150M
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $3.169M $3.171M $3.170M
YoY Change -0.11% -5.07%
TOTAL ASSETS
Total Short-Term Assets $2.994K $54.15K $19.59K
Total Long-Term Assets $3.169M $3.171M $3.170M
Total Assets $3.172M $3.225M $3.190M
YoY Change -1.95% -10.0% 17711.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $627.1K $557.0K $435.7K
YoY Change 297.27% 802.82% 1143.55%
Accrued Expenses $868.3K $720.6K $618.1K
YoY Change 7631.52% 26006.88%
Deferred Revenue
YoY Change
Short-Term Debt $426.0K $302.9K $124.1K
YoY Change 1978.1% 1919.4% 107.21%
Long-Term Debt Due $262.5K $362.5K $687.5K
YoY Change -43.24% 1018.83%
Total Short-Term Liabilities $2.184M $1.943M $1.865M
YoY Change 234.9% 1636.99% 887.16%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.184M $1.943M $1.865M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $2.184M $1.943M $1.865M
YoY Change 234.9% 1636.99% 887.16%
SHAREHOLDERS EQUITY
Retained Earnings -$3.193M -$2.791M
YoY Change
Common Stock $28.06K $27.91K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $988.6K $1.282M $1.325M
YoY Change
Total Liabilities & Shareholders Equity $3.172M $3.225M $3.190M
YoY Change -1.95% -10.0% 17711.5%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$401.5K -$454.5K -$387.9K
YoY Change -7.39% 36.42% 2229.67%
Depreciation, Depletion And Amortization $1.340K $1.290K $1.200K
YoY Change -99.24% -99.26%
Cash From Operating Activities -$175.6K -$202.7K -$110.7K
YoY Change -44.2% 26.81% 295.5%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$1.580K
YoY Change -100.0% -89.57%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$1.580K
YoY Change -100.0% -89.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 123.1K 238.8K 118.2K
YoY Change -13.92% -29.77%
NET CHANGE
Cash From Operating Activities -175.6K -202.7K -110.7K
Cash From Investing Activities 0.000 -1.580K
Cash From Financing Activities 123.1K 238.8K 118.2K
Net Change In Cash -52.46K 34.56K $0.00
YoY Change -70.94% -79.06%
FREE CASH FLOW
Cash From Operating Activities -$175.6K -$202.7K -$110.7K
Capital Expenditures $0.00 -$1.580K
Free Cash Flow -$175.6K -$201.1K -$110.7K
YoY Change -42.58% 38.99% 295.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001657045
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
28022497 shares
CY2022Q2 us-gaap Cash
Cash
52554 usd
CY2021Q2 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Stock Issued1
StockIssued1
usd
CHMX Common Stock Issued On Conversion Of Notes Payable And Accrued Interest
CommonStockIssuedOnConversionOfNotesPayableAndAccruedInterest
usd
CHMX Common Stock Issued On Conversion Of Related Party Notes Payable And Accrued Interest
CommonStockIssuedOnConversionOfRelatedPartyNotesPayableAndAccruedInterest
usd
CHMX Cancellation Of Shares
CancellationOfShares
usd
CHMX Beneficial Conversion Feature
BeneficialConversionFeature
usd
CHMX Related Party Debt Forgiveness
RelatedPartyDebtForgiveness
usd
CY2021Q4 CHMX Accrued Interest Related Party
AccruedInterestRelatedParty
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56379
dei Entity Registrant Name
EntityRegistrantName
NEXT-ChemX Corporation
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
32-0446353
dei Entity Address Address Line1
EntityAddressAddressLine1
1111 W 12th St
dei Entity Address Address Line2
EntityAddressAddressLine2
# 113
dei Entity Address City Or Town
EntityAddressCityOrTown
Austin
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
78703
dei City Area Code
CityAreaCode
(512)
dei Local Phone Number
LocalPhoneNumber
663-2690
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
CY2021Q4 us-gaap Cash
Cash
10429 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1600 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1600 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
54154 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
12029 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20625 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21540 usd
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3150114 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3150114 usd
CY2022Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
3170739 usd
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
3171654 usd
CY2022Q2 us-gaap Assets
Assets
3224893 usd
CY2021Q4 us-gaap Assets
Assets
3183683 usd
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1277595 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
777797 usd
CY2022Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
347500 usd
CY2021Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
672500 usd
CY2022Q2 CHMX Convertible Notes Payable Related Party Current
ConvertibleNotesPayableRelatedPartyCurrent
15000 usd
CY2021Q4 CHMX Convertible Notes Payable Related Party Current
ConvertibleNotesPayableRelatedPartyCurrent
15000 usd
CY2022Q2 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
301007 usd
CY2022Q2 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
1900 usd
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
5900 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1943002 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1471197 usd
CY2022Q2 us-gaap Liabilities
Liabilities
1943002 usd
CY2021Q4 us-gaap Liabilities
Liabilities
1471197 usd
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27914383 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27914383 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27385437 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27385437 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
27913 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
27385 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4045326 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
438301 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
298005 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3634034 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2791348 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1948933 usd
us-gaap Operating Expenses
OperatingExpenses
812410 usd
us-gaap Operating Expenses
OperatingExpenses
314655 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-438301 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-298005 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-812410 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-314655 usd
CY2022Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
16224 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1281891 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1712486 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3224893 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3183683 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
438301 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
298005 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
812410 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
314655 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
3471443 usd
us-gaap Net Income Loss
NetIncomeLoss
-842415 usd
us-gaap Net Income Loss
NetIncomeLoss
-349836 usd
CY2021Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
35181 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
30005 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
35181 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-16224 usd
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-35181 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-30005 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-35181 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-454525 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2492 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-333186 usd
us-gaap Net Income Loss
NetIncomeLoss
-842415 usd
us-gaap Net Income Loss
NetIncomeLoss
-349836 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27914383 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8958989 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27914383 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15576222 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1712486 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-387890 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1324596 usd
CY2022Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
351361 usd
CY2022Q2 CHMX Stock Issued During Period Value Conversion Of Related Party
StockIssuedDuringPeriodValueConversionOfRelatedParty
60459 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-454525 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1281891 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-154408 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-16650 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-171058 usd
CY2021Q2 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
3500127 usd
CY2021Q2 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
325000 usd
CY2021Q2 CHMX Related Party Debt Forgiveness
RelatedPartyDebtForgiveness
150560 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-333186 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
175259 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
32397 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
59458 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
526618 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
13849 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-313305 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-187789 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1577 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15150 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1577 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15150 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
325000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
60000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
15000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
301007 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
4000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
357007 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
340000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
42125 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
137061 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10429 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
44619 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
52554 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
181680 usd
us-gaap Stock Issued1
StockIssued1
3500127 usd
CHMX Common Stock Issued On Conversion Of Notes Payable And Accrued Interest
CommonStockIssuedOnConversionOfNotesPayableAndAccruedInterest
351361 usd
CHMX Common Stock Issued On Conversion Of Related Party Notes Payable And Accrued Interest
CommonStockIssuedOnConversionOfRelatedPartyNotesPayableAndAccruedInterest
60459 usd
CHMX Cancellation Of Shares
CancellationOfShares
5418 usd
CHMX Beneficial Conversion Feature
BeneficialConversionFeature
325000 usd
CHMX Related Party Debt Forgiveness
RelatedPartyDebtForgiveness
150560 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2791348 usd
us-gaap Net Income Loss
NetIncomeLoss
-842415 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-313305 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_841_eus-gaap--UseOfEstimates_zPcL99hRAbkk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_zsDB0zrglN8j">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
us-gaap Adjustment For Amortization
AdjustmentForAmortization
3150114 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1600 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1600 usd
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3150114 usd
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
60000 usd
CY2022Q2 CHMX Common Stock Shares Outstanding Unchanged
CommonStockSharesOutstandingUnchanged
27914383 shares
CY2021Q4 CHMX Common Stock Shares Outstanding Unchanged
CommonStockSharesOutstandingUnchanged
27385437 shares
CY2022Q2 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
557041 usd
CY2021Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
394530 usd
CY2022Q2 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
694674 usd
CY2021Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
360500 usd
CY2022Q2 us-gaap Interest Payable Current
InterestPayableCurrent
25015 usd
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
22767 usd
CY2022Q2 CHMX Accrued Interest Related Party
AccruedInterestRelatedParty
865 usd
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1277595 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
777797 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
30005 usd
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001

Files In Submission

Name View Source Status
0001493152-22-022720-index-headers.html Edgar Link pending
0001493152-22-022720-index.html Edgar Link pending
0001493152-22-022720.txt Edgar Link pending
0001493152-22-022720-xbrl.zip Edgar Link pending
chmx-20220630.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
chmx-20220630_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
chmx-20220630_pre.xml Edgar Link unprocessable
chmx-20220630_lab.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
Show.js Edgar Link pending
chmx-20220630_def.xml Edgar Link unprocessable